title: Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis.
abstract: There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survival. In order to test this opinion, we performed a retrospective analysis comparing results of 56 consecutive patients with polycystic kidney disease to 56 non-diabetic patients with bilateral small kidneys. The patient groups were all initiated on peritoneal dialysis over a 12 year period and matched for age, gender and years of end stage renal failure. After a mean follow-up period of 37 months the two groups were statistically indistinguishable in terms of mortality, kidney transplantation-censored technique survival, median death-censored technique survival, the number of patients switched permanently to hemodialysis due to technique failure and the rate of peritonitis. On Cox regression (multivariate) analysis, only the baseline serum albumin level was a significant and independent risk factor of death-censored technique failure. Our study found no difference in long term outcome of peritoneal dialysis therapy in patients with polycystic kidney disease compared to a non-diabetic matched control group.
authors.affiliation: Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts and the London NHS Trust, Whitechapel, London, UK. drksanjeev@yahoo.com
authors.forename: Sanjeev
authors.initials: S
authors.lastname: Kumar
authors.forename: Stanley L-S
authors.initials: SL
authors.lastname: Fan
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Raftery
authors.forename: Magdi M
authors.initials: MM
authors.lastname: Yaqoob
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000401:mortality*; D010538:Peritonitis / Q000209:etiology; D016891:Polycystic Kidney, Autosomal Dominant / Q000150:complications / Q000401:mortality* / Q000628:therapy; D012189:Retrospective Studies; D012307:Risk Factors; D012709:Serum Albumin / Q000032:analysis; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D012709:Serum Albumin